News | July 11, 2023
Sumitomo Pharma America launches as new combined organization
SMPA's diverse portfolio includes six marketed products and a robust pipeline of early- to late-stage assets
SMPA's diverse portfolio includes six marketed products and a robust pipeline of early- to late-stage assets
Under the terms of the collaboration, Vertex and Lonza will partner in the process development and scale-up for the manufacturing of the product portfolio and co-invest to build a dedicated new facility in Portsmouth, New Hampshire (US)
Sajjan India Limited is looking for expansion, both organically and through acquisitions, to achieve the planned growth
Urges Innovators to produce quality products that can be deployed at scale
Patent Term Extension is designed to restore some of the patent life lost during the regulatory review process for new drugs.
Acuitas Therapeutics' LNP technology will support Bayer’s in vivo gene editing and protein replacement programs with the goal of specifically delivering RNA payloads to the desired target organ, the liver.
Acquisition will further strengthen Lonza’s bioconjugates offering through the integration of the industry-leading proprietary Synaffix technology platform and R&D capabilities, including payload and site-specific linker technology
Synexa joins CEPI’s esteemed Central Lab Network to improve global epidemic preparedness
Aim of the agreement is to expand the full potential of Beren’s cyclodextrin technologies and their medicinal applications.
Both the companies intend to facilitate faster clinical trial enrollment and provide patients with access to novel medications
Subscribe To Our Newsletter & Stay Updated
